ClinicalTrials.gov
public full text
Public Domain
Evaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult Subjects
RPX7009(beta-lactamase inhibitor) is being studied in combination with a carbapenem (RPX2014) to treat bacterial infections, including those due to multi-drug resistant bacteria.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Rôle des lipides de surface dans la spécificité des interactions entre Mycobacterium abscessus et les mycobactériophages#262039
- Bacteriophage Therapy of Difficult-to-treat Infections#329550
- Advancements and challenges in the medical treatment of monkeypox: A recent focused review#704198
- Lactate promotes IL-8 secretion in human alveolar macrophages through GPR132 and lipid metabolic reprogramming#279915
- Bacteriophage therapy for Pseudomonas aeruginosa biofilms: mechanisms of resistance and novel treatment strategies#366765
Record · ID 1243899
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive